Implantable Cardioverter-defibrillator Utilization and Its Outcomes in Korea: Data from Korean Acute Heart Failure Registry|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background: There are sparse data on the utilization rate of implantable cardioverter- defibrillator (ICD) and its beneficial effects in Korean patients with heart failure with reduced left ventricular ejection fraction (LVEF).
Methods: Among 5,625 acute heart failure (AHF) patients from 10 tertiary university hospitals across Korea, 485 patients with reassessed LVEF ≤ 35% at least 3 months after the index admission were enrolled in this study. The ICD implantation during the follow-up was evaluated. Mortality was compared between patients with ICDs and age-, sex-, and follow-up duration matched control patients.
Results: Among 485 patients potentially indicated for an ICD for primary prevention, only 56 patients (11.5%) underwent ICD implantation during the follow-up. Patients with ICD showed a significantly lower all-cause mortality compared with their matched control population: adjusted hazard ratio (HR) (95% confidence interval [CI]) = 0.39 (0.16–0.92), P = 0.032. The mortality rate was still lower in the ICD group after excluding patients with cardiac resynchronization therapy (adjusted HR [95% CI] = 0.09 [0.01–0.63], P = 0.015).
According to the subgroup analysis for ischemic heart failure, there was a significantly lower all-cause mortality in the ICD group than in the no-ICD group (HR [95% CI] = 0.20 [0.06– 0.72], P = 0.013), with a borderline statistical significance (interaction P = 0.069).
Conclusion: Follow-up data of this large, multicenter registry suggests a significant under- utilization of ICD in Korean heart failure patients with reduced LVEF. Survival analysis implies that previously proven survival benefit of ICD in clinical trials could be extrapolated to Korean patients.

번역하기

참고문헌 (Reference)

1 김용훈, "삽입형 심실제세동기 시술 환자의 임상적 특성" 대한심장학회 34 (34): 395-404, 2004

2 Roh SY, "Trends in the use of implantable cardioverterdefibrillators for prevention of sudden cardiac arrest : A South Korean nationwide population-based study" 42 (42): 1086-1094, 2019

3 Fisher ES, "The implications of regional variations in Medicare spending. Part 2 : health outcomes and satisfaction with care" 138 (138): 288-298, 2003

4 Fisher ES, "The implications of regional variations in Medicare spending. Part 1 : the content, quality, and accessibility of care" 138 (138): 273-287, 2003

5 Matlock DD, "Regional variation in the use of implantable cardioverter-defibrillators for primary prevention : results from the national cardiovascular data registry" 4 (4): 114-121, 2011

6 Pokorney SD, "Reassessment of cardiac function and implantable cardioverter-defibrillator use among medicare patients with low ejection fraction after myocardial infarction" 135 (135): 38-47, 2017

7 Hohnloser SH, "Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction" 351 (351): 2481-2488, 2004

8 Moss AJ, "Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction" 346 (346): 877-883, 2002

9 Kadish A, "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy" 350 (350): 2151-2158, 2004

10 Kang J, "Predictors and prognostic value of worsening renal function during admission in HFpEF versus HFrEF : data from the KorAHF(Korean Acute Heart Failure)registry" 7 (7): e007910-, 2018